Cardiopulmonary Autotransfusion System is a sophisticated device with an exceptionally effective design that provides autologous blood during surgical procedures.
Autotransfusion is a process wherein a person receives their own blood for a transfusion, instead of banked allogenic (separate-donor) blood. There are two main kinds of Autotransfusion: Blood can be autologous "pre-donated" (termed so despite "donation" not typically referring to giving to one's self) before a surgery, or alternatively, it can be collected during and after the surgery using an intraoperative blood salvage device. The latter form of Autotransfusion is utilized in surgeries where there is expected a large volume blood loss.
The rising prevalence of cardiovascular diseases (CVDs), advancements in technology, and increasing investments in R&D are some of the factors that will propel growth in the cardiopulmonary Autotransfusion systems market in the Americas during the forecast period.
Cardiac surgeries are complex and may result in a significant loss of blood during deep surgical incisions. This can lower the balance of blood in the body and increase the risks of surgery-induced anemia in people after surgery. This leads to the demand for significant volumes of blood supply, which depends on the complexity of the surgery.
According to this study, over the next five years the Cardiopulmonary Autotransfusion System market will register a 2.5% CAGR in terms of revenue, the global market size will reach US$ 590 million by 2024, from US$ 510 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Cardiopulmonary Autotransfusion System business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Cardiopulmonary Autotransfusion System market by product type, application, key manufacturers and key regions and countries.
This study considers the Cardiopulmonary Autotransfusion System value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Unwashed ATS
Washed ATS
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Heart Surgery
Great Organ Transplant Surgery
Other Surgery
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Haemonetics
Medtronic
LivaNova
Fresenius Kabi
Terumo
Wandong Health Sources
...
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Cardiopulmonary Autotransfusion System consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Cardiopulmonary Autotransfusion System market by identifying its various subsegments.
Focuses on the key global Cardiopulmonary Autotransfusion System manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Cardiopulmonary Autotransfusion System with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Cardiopulmonary Autotransfusion System submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
2019-2024 Global Cardiopulmonary Autotransfusion System Consumption Market Report
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Cardiopulmonary Autotransfusion System Consumption 2014-2024
2.1.2 Cardiopulmonary Autotransfusion System Consumption CAGR by Region
2.2 Cardiopulmonary Autotransfusion System Segment by Type
2.2.1 Unwashed ATS
2.2.2 Washed ATS
2.3 Cardiopulmonary Autotransfusion System Consumption by Type
2.3.1 Global Cardiopulmonary Autotransfusion System Consumption Market Share by Type (2014-2019)
2.3.2 Global Cardiopulmonary Autotransfusion System Revenue and Market Share by Type (2014-2019)
2.3.3 Global Cardiopulmonary Autotransfusion System Sale Price by Type (2014-2019)
2.4 Cardiopulmonary Autotransfusion System Segment by Application
2.4.1 Heart Surgery
2.4.2 Great Organ Transplant Surgery
2.4.3 Other Surgery
2.5 Cardiopulmonary Autotransfusion System Consumption by Application
2.5.1 Global Cardiopulmonary Autotransfusion System Consumption Market Share by Application (2014-2019)
2.5.2 Global Cardiopulmonary Autotransfusion System Value and Market Share by Application (2014-2019)
2.5.3 Global Cardiopulmonary Autotransfusion System Sale Price by Application (2014-2019)
3 Global Cardiopulmonary Autotransfusion System by Players
3.1 Global Cardiopulmonary Autotransfusion System Sales Market Share by Players
3.1.1 Global Cardiopulmonary Autotransfusion System Sales by Players (2017-2019)
3.1.2 Global Cardiopulmonary Autotransfusion System Sales Market Share by Players (2017-2019)
3.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Players
3.2.1 Global Cardiopulmonary Autotransfusion System Revenue by Players (2017-2019)
3.2.2 Global Cardiopulmonary Autotransfusion System Revenue Market Share by Players (2017-2019)
3.3 Global Cardiopulmonary Autotransfusion System Sale Price by Players
3.4 Global Cardiopulmonary Autotransfusion System Manufacturing Base Distribution, Sales Area, Product Types by Players
3.4.1 Global Cardiopulmonary Autotransfusion System Manufacturing Base Distribution and Sales Area by Players
3.4.2 Players Cardiopulmonary Autotransfusion System Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Cardiopulmonary Autotransfusion System by Regions
4.1 Cardiopulmonary Autotransfusion System by Regions
4.1.1 Global Cardiopulmonary Autotransfusion System Consumption by Regions
4.1.2 Global Cardiopulmonary Autotransfusion System Value by Regions
4.2 Americas Cardiopulmonary Autotransfusion System Consumption Growth
4.3 APAC Cardiopulmonary Autotransfusion System Consumption Growth
4.4 Europe Cardiopulmonary Autotransfusion System Consumption Growth
4.5 Middle East & Africa Cardiopulmonary Autotransfusion System Consumption Growth
5 Americas
5.1 Americas Cardiopulmonary Autotransfusion System Consumption by Countries
5.1.1 Americas Cardiopulmonary Autotransfusion System Consumption by Countries (2014-2019)
5.1.2 Americas Cardiopulmonary Autotransfusion System Value by Countries (2014-2019)
5.2 Americas Cardiopulmonary Autotransfusion System Consumption by Type
5.3 Americas Cardiopulmonary Autotransfusion System Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Cardiopulmonary Autotransfusion System Consumption by Countries
6.1.1 APAC Cardiopulmonary Autotransfusion System Consumption by Countries (2014-2019)
6.1.2 APAC Cardiopulmonary Autotransfusion System Value by Countries (2014-2019)
6.2 APAC Cardiopulmonary Autotransfusion System Consumption by Type
6.3 APAC Cardiopulmonary Autotransfusion System Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Cardiopulmonary Autotransfusion System by Countries
7.1.1 Europe Cardiopulmonary Autotransfusion System Consumption by Countries (2014-2019)
7.1.2 Europe Cardiopulmonary Autotransfusion System Value by Countries (2014-2019)
7.2 Europe Cardiopulmonary Autotransfusion System Consumption by Type
7.3 Europe Cardiopulmonary Autotransfusion System Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Cardiopulmonary Autotransfusion System by Countries
8.1.1 Middle East & Africa Cardiopulmonary Autotransfusion System Consumption by Countries (2014-2019)
8.1.2 Middle East & Africa Cardiopulmonary Autotransfusion System Value by Countries (2014-2019)
8.2 Middle East & Africa Cardiopulmonary Autotransfusion System Consumption by Type
8.3 Middle East & Africa Cardiopulmonary Autotransfusion System Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Cardiopulmonary Autotransfusion System Distributors
10.3 Cardiopulmonary Autotransfusion System Customer
11 Global Cardiopulmonary Autotransfusion System Market Forecast
11.1 Global Cardiopulmonary Autotransfusion System Consumption Forecast (2019-2024)
11.2 Global Cardiopulmonary Autotransfusion System Forecast by Regions
11.2.1 Global Cardiopulmonary Autotransfusion System Forecast by Regions (2019-2024)
11.2.2 Global Cardiopulmonary Autotransfusion System Value Forecast by Regions (2019-2024)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Cardiopulmonary Autotransfusion System Forecast by Type
11.8 Global Cardiopulmonary Autotransfusion System Forecast by Application
12 Key Players Analysis
12.1 Haemonetics
12.1.1 Company Details
12.1.2 Cardiopulmonary Autotransfusion System Product Offered
12.1.3 Haemonetics Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Gross Margin (2017-2019)
12.1.4 Main Business Overview
12.1.5 Haemonetics News
12.2 Medtronic
12.2.1 Company Details
12.2.2 Cardiopulmonary Autotransfusion System Product Offered
12.2.3 Medtronic Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Gross Margin (2017-2019)
12.2.4 Main Business Overview
12.2.5 Medtronic News
12.3 LivaNova
12.3.1 Company Details
12.3.2 Cardiopulmonary Autotransfusion System Product Offered
12.3.3 LivaNova Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Gross Margin (2017-2019)
12.3.4 Main Business Overview
12.3.5 LivaNova News
12.4 Fresenius Kabi
12.4.1 Company Details
12.4.2 Cardiopulmonary Autotransfusion System Product Offered
12.4.3 Fresenius Kabi Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Gross Margin (2017-2019)
12.4.4 Main Business Overview
12.4.5 Fresenius Kabi News
12.5 Terumo
12.5.1 Company Details
12.5.2 Cardiopulmonary Autotransfusion System Product Offered
12.5.3 Terumo Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Gross Margin (2017-2019)
12.5.4 Main Business Overview
12.5.5 Terumo News
12.6 Wandong Health Sources
12.6.1 Company Details
12.6.2 Cardiopulmonary Autotransfusion System Product Offered
12.6.3 Wandong Health Sources Cardiopulmonary Autotransfusion System Sales, Revenue, Price and Gross Margin (2017-2019)
12.6.4 Main Business Overview
12.6.5 Wandong Health Sources News
...
13 Research Findings and Conclusion
List of Tables and Figures
Figure Picture of Cardiopulmonary Autotransfusion System
Table Product Specifications of Cardiopulmonary Autotransfusion System
Figure Cardiopulmonary Autotrans